Treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan by Hanako Nishimoto, Atsuyuki Inui, Yutaka Mifune, Kohei Yamaura, Yukari Bando, Yasuyoshi Okamura, Takuto Hara, Tomoaki Terakawa, Ryosuke Kuroda

Subjects: Get full text

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004 by R Miralbell, S Pampallona, M Rouzaud, A Pugliesi, D Weber, C Ares

Subjects: “…Androgen deprivation…”
Get full text

Clinical efficacy of different androgen deprivation therapies for prostate cancer and evaluation based on dynamic-contrast enhanced magnetic resonance imaging by WenXiao Guo, MengZhu Li

Subjects: Get full text

Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dots by Per-Anders Abrahamsson

Subjects: “…Continuous androgen deprivation therapy…”
Get full text

Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control... by Vaios-Konstantinos Mytilekas, Efstathios Papaefstathiou, Periklis Koukourikis, Xenofon Ouzounidis, Stavros Kazantzidis, Konstantinos Hatzimouratidis

Subjects: “…androgen deprivation therapy…”
Get full text

Remission of Membranous Nephropathy after Treatment of Localised Prostate Cancer by Daniel Adlington, Jason Moore, Coralie Bingham

Subjects: Get full text

Impact of tumor cytoreduction in metastatic prostate cancer by Sow Y, Sow O, Fall B, Sine B, Sarr A, Zé Ondo C, Diao B, Ndoye AK, Ba M

Subjects: Get full text

Differences in Hypercholesterolemia and Atherogenesis Induced by Common Androgen Deprivation Therapies in Male Mice by Christian Bo Poulsen, Martin Bødtker Mortensen, Wolfgang Koechling, Charlotte Brandt Sørensen, Jacob Fog Bentzon

Subjects: “…androgen deprivation therapy…”
Get full text

The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patients by Orwa Dandash, James Allebone, Adam Mirabelli, Nicholas Russell, Mathis Grossmann, Andrea Gogos, Richard A Kanaan

Subjects: Get full text

No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study by Liu JM, Lin CY, Chuang HC, Hsu RJ

Subjects: Get full text

Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer by Wook Nam, Se Young Choi, Sang Jun Yoo, Jeman Ryu, Jaehoon Lee, Yoon Soo Kyung, Jae Hyeon Han, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim

Subjects: “…Androgen deprivation therapy…”
Get full text

Fisetin as an adjuvant treatment in prostate cancer patients receiving androgen-deprivation therapy by Giuseppe Di Lorenzo, Luca Scafuri, Ferdinando Costabile, Liuba Pepe, Anna Scognamiglio, Felice Crocetto, Germano Guerra, Carlo Buonerba

Subjects: “…androgen deprivation therapy…”
Get full text

A Comprehensive Review of Androgen Deprivation Therapy and Immunotherapy on Prostate Cancer by ZHU Hui, DENG Kangli

Subjects: “…androgen deprivation therapy…”
Get full text

Incidence of prostate cancer in transgender women undergoing androgen deprivation therapy: A review by Saurabh Tyagi, Surbhi Tyagi

Subjects: “…androgen deprivation therapy…”
Get full text

Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer by Jonathan Q. Purnell, Lisa B. Bland, Mark Garzotto, Dianne Lemmon, Emily M. Wersinger, Christopher W. Ryan, John D. Brunzell, Tomasz M. Beer

Subjects: Get full text

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review by Herjan J.T. Coelingh Bennink, Jan F.M. Egberts, Frans M.J. Debruyne

Subjects: “…Androgen-deprivation therapy…”
Get full text

Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2) by A.M. Algotar, R. Kumar, H.M. Babiker, S.T. Dougherty, C.H. Hsu, H.-H. Chow, T.E. Smith, D.G. Marrero, K.S. Courneya, I. Abraham, J.A. Ligibel, C.A. Thomson

Subjects: Get full text

A 6-month sustained-release formulation of triptorelin for locally advanced or metastatic prostate cancer: a real-world experience in Asia by Chi-Hang Yee, Yuen-Hei Chung, Ivan Ching-Ho Ko, Chris Ho-Ming Wong, Alex Mok, Jeremy Yuen-Chun Teoh, Peter Ka-Fung Chiu, Chi-Fai Ng

Subjects: Get full text

The impact of androgen deprivation therapy on the lipid profile in patients with prostate carcinoma by Niraj Kumar, Vibha Vasudeva, Siddharth Yadav, Vishnu Prasad, Samarth Patel

Subjects: Get full text

Dramatic mixed response of lymphangitic pulmonary metastases in newly diagnosed prostate cancer by Elan Gorshein, Robin Burger, Anna Ferrari, Tina Mayer

Subjects: “…Androgen deprivation therapy…”
Get full text